CNS Active Drugs -- Behavioural Modifiers
Azaperone (Stresnil®, Suicalm®) -- A butyrophenone derivative ataractic that acts as a dopamine antagonist. Ethylisobutrazine (Diquel®) -- Diazepam (Valium®) -- A human benzodiazepine that acts as to enhance GABAergic transmission, some of the veterinary uses are similar to approved human indications, such as white shaker dog syndrome and Scottie cramp. Oxazepam (Serax®) -- Buspirone (BusPar®) -- Amitriptyline -- A tricyclic antidepressant that inhibits the re-uptake of noradrenaline and serotonin. Clomipramine (Clomicalm®) -- In January 1999, this tricyclic antidepressant was the first drug to officially receive FDA approval for the treatment of canine separation anxiety in dogs over 6 months old.  The dose is 1-2 mg/Kg twice daily for a maximum daily dose of 2-4 mg/Kg.

Fluoxetine (Prozac®) -- This selective serotonin re-uptake inhibitor is used in the treatment of stereotypy, obsessive-compulsive behaviour, and phobias in small animals and canine aggression.  Overdose may cause seizures.

Selegiline (Anipryl®) -- In January 1999, the FDA also approved the use of this selective monoamine oxidase B inhibitor for the treatment of canine cognitive dysfunction syndrome (CDS).  The dose for CDS is 0.5-1 mg/Kg.  Selegiline is also used in the treatment of canine Cushing's syndrome at a dose of 1-2 mg/Kg.

Go To Next Topic -- Miscellaneous Drugs Used In Veterinary Practice